Results 151 to 160 of about 7,227 (222)

Restoring well-being: quality of life improvements following dolutegravir-based therapy after antiretroviral failure. [PDF]

Braz J Infect Dis
Lins-Kusterer L, Brites C, de Lacerda MVG, Page K, Bahia F, Luz E, Ramalho A, Wagner S, Arriaga MB, CODE research group collaborators.   +9 more
europepmc   +1 more source

Prevalence of Potentially Inappropriate Apixaban Prescribing Within a Single-Centre Tertiary Hospital. [PDF]

Australas J Ageing
Creeper KJ, Lenaghan G, Stockwell A, Schmidt M, Ingram K, Stafford AC.   +5 more
europepmc   +1 more source

Residue‑resolved dynamically averaged interaction analysis of direct factor Xa inhibitors by MD‑FMO combination calculations. [PDF]

J Comput Aided Mol Des
Yoshine R, Hirano Y, Doi H, Kitahara S, Akisawa K, Okuwaki K, Yamamoto E, Yasuoka K, Mochizuki Y.   +8 more
europepmc   +1 more source

Crystal structure, spectroscopy, DFT, and thermal studies of 3-cyano-2(1H)-pyridones as potential anticancer agents. [PDF]

RSC Adv
Hurtado-Rodríguez D, Becerra D, Rojas H, Gómez Castaño JA, Macías MA, Castillo JC.   +5 more
europepmc   +1 more source

Pathologic and radiologic response to neoadjuvant therapy in advanced differentiated thyroid cancer. [PDF]

Eur Thyroid J
Kampel L, Dorman A, Trejo LL, Krol K, Huber RK, Kravchenko Y, Antebi Y, Shendler G, Joshua BZ, Alon E, Warshavsky A, Horowitz G, Shilo S, Muhanna N, Finkel I.   +14 more
europepmc   +1 more source

Takotsubo Syndrome Following Combination Therapy with Dabrafenib and Trametinib. [PDF]

Intern Med
Nishikawa T, Ohe S, Suzuki Y, Kobayashi M, Tateishi S, Yamane Y, Bun S, Sakamoto R, Kurokami Y, Yamamoto H, Yasui T, Fujita M.   +11 more
europepmc   +1 more source

Prothrombin complex concentrate for oral factor Xa inhibitor reversal prior to urgent invasive procedures. [PDF]

Transfusion
Shamiea M, Osnis A, Kashoua A, Avnery O, Itchaki G, Isman S, Tohami T, Jarchowsky-Dolberg O, Ellis M.   +8 more
europepmc   +1 more source

Bis(μ-1,4-di-hydro-pyridin-4-one-κ² <i>O</i>:<i>O</i>)di-μ-perchlorato-κ⁴ <i>O</i>:<i>O</i>'-bis-[aqua-(1,4-di-hydro-pyridin-4-one-κ<i>O</i>)copper(II)] tetra-aqua-bis-(1,4-di-hydropyridin-4-one-κ<i>O</i>)copper(II) tetra-kis-(perchlorate) 1,4-di-hydro-pyridin-4-one disolvate. [PDF]

IUCrdata
Turnbull MM, Landee CP, Wikaira JL.
europepmc   +1 more source

Efficacy and metabolic outcomes of switching from an INSTI-based triple-drug regimen to dolutegravir/lamivudine in treatment-experienced HIV-1-infected patients: a 48-week real-world study. [PDF]

Ann Med
Zhang W, Li Q, Deng C, Yuan J.
europepmc   +1 more source

Recurrent Stroke and Progression of Left Ventricular Thrombus During Apixaban Therapy in a Patient with Severe Ischemic Cardiomyopathy: A Case Report. [PDF]

Am J Case Rep
Babonji A, Algethmi FA, Almutairi BS, Alsulami A, Al-Mrzouki AF.   +4 more
europepmc   +1 more source